NCT04788615 Open Label Randomized Multicenter to Assess Efficacy & Tolerability of Ofatumumab 20mg vs. First Line DMT in RMS Status COMPLETED Phase PHASE3
NCT04787497 The Effect of Extra Virgin Olive Oil in People With Multiple Sclerosis Status ACTIVE_NOT_RECRUITING Phase NA
NCT04786821 Acceptability of Exoskeleton Assisted Walking for Persons With Mobility Issues Due to Multiple Sclerosis Status COMPLETED Phase NA
NCT04783935 Extension to the MAGNIFY MS Trial on Mavenclad® (Magnify MS Extension) Status COMPLETED Phase PHASE4
NCT04776213 Cognition and HRQoL in Adults With Highly-active RMS in Year 3 and 4 After Initial Mavenclad® Dose (CLARIFY MS Extension) Status COMPLETED Phase PHASE4
NCT04771858 Digital Gait Analysis in the Home Environment of Patients With Multiple Sclerosis Status COMPLETED Phase N/A
NCT04767698 Addition of Belimumab to B-cell Depletion in Relapsing-remitting Multiple Sclerosis Status TERMINATED Phase PHASE2
NCT04760990 A Study to Assess the Potential Impact of Disease Modifying Therapies on COVID-19 Outcomes and the Antibody Response Following an Infection With SARS-CoV-2 in Patients With Multiple Sclerosis Within the Swiss Multiple Sclerosis Cohort. Status COMPLETED Phase N/A
NCT04758494 Quality of Life Assessment Between Stroke and Multiple Sclerosis Patients of the Same Age Range Status COMPLETED Phase N/A
NCT04758468 Effects of Telerehabilitation-Based Pelvic Floor Muscle Training in People With Multiple Sclerosis Status COMPLETED Phase NA
NCT04756700 Validation of DigiCog and Konectom Tools to Support Digitalized Clinical Assessment in Multiple Sclerosis Status COMPLETED Phase NA
NCT04756687 Real World Analysis on Lymphocyte Reconstitution After Lymphopenia in Participants Treated by Tecfidera Status COMPLETED Phase N/A
NCT04754542 Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS): Extension of the DISCOMS Study Status COMPLETED Phase N/A
NCT04750733 Impact of Core Performance on Functional Parameters in Multiple Sclerosis Status COMPLETED Phase N/A
NCT04749667 Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2